UC Berkeley researchers trained AI to detect hidden warning signs of sudden cardiac death in routine ECG tests, according to ...
The FDA cleared EchoNext, the first artificial intelligence tool to detect structural heart disease before symptoms present.
Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Illustration by Anumana // Why bring AI into a test that has been around for a hundred years ...
In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...
AI/ML Innovations Inc. is a technology company developing artificial intelligence and neural-network solutions for digital health. Its proprietary technology applies advanced signal processing and ...
Southlake, TX, June 02, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information ...
A study was conducted to determine the diagnostic performance of AI ECG interpretation for diagnosing STEMI. Pulmonology Advisor, a trusted source of medical news and feature content for healthcare ...
A study was conducted to determine the diagnostic performance of AI ECG interpretation for diagnosing STEMI. Artificial intelligence-based algorithms that utilize electrocardiogram data demonstrate ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results